Actively Recruiting
Physiologic MR Imaging of Salivary Gland Tumors
Led by Abramson Cancer Center at Penn Medicine · Updated on 2025-09-09
30
Participants Needed
1
Research Sites
300 weeks
Total Duration
On this page
Sponsors
A
Abramson Cancer Center at Penn Medicine
Lead Sponsor
M
McCabe Fund
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.
CONDITIONS
Official Title
Physiologic MR Imaging of Salivary Gland Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Possess a salivary gland lesion of 1cm3 size
- Have no prior history of treatment for salivary gland lesion
You will not qualify if you...
- Has any prior history of cancer other than salivary gland tumor
- Has any MRI contraindications
- Has a history of known renal disease
- Has history of prior radiation to head and neck region
- Is pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
M
Marisa Sanchez
CONTACT
L
Lisa Desiderio
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here